Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 18258980)

1.

Clinical application of the 70-gene profile: the MINDACT trial.

Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ.

J Clin Oncol. 2008 Feb 10;26(5):729-35. doi: 10.1200/JCO.2007.14.3222.

2.

The MINDACT trial: the first prospective clinical validation of a genomic tool.

Cardoso F, Piccart-Gebhart M, Van't Veer L, Rutgers E; TRANSBIG Consortium.

Mol Oncol. 2007 Dec;1(3):246-51. doi: 10.1016/j.molonc.2007.10.004. Epub 2007 Oct 22.

3.

[Gene expression profiles for therapeutic decisions in breast cancer].

Corvalán A.

Rev Med Chil. 2007 Feb;135(2):257-63. Epub 2007 Mar 28. Spanish.

4.

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Mook S, Van't Veer LJ, Rutgers EJ, Piccart-Gebhart MJ, Cardoso F.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):147-55. Review.

5.

Critical review of microarray-based prognostic tests and trials in breast cancer.

Koscielny S.

Curr Opin Obstet Gynecol. 2008 Feb;20(1):47-50. doi: 10.1097/GCO.0b013e3282f39d9e. Review.

PMID:
18197005
6.

Daily clinical practice of fresh tumour tissue freezing and gene expression profiling; logistics pilot study preceding the MINDACT trial.

Mook S, Bonnefoi H, Pruneri G, Larsimont D, Jaskiewicz J, Sabadell MD, Macgrogan G, Van't Veer LJ, Cardoso F, Rutgers EJ.

Eur J Cancer. 2009 May;45(7):1201-8. doi: 10.1016/j.ejca.2009.01.004. Epub 2009 Feb 14.

PMID:
19232484
7.

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial.

Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N, Ravdin P, Therasse P, Rutgers E, van 't Veer LJ, Piccart M; TRANSBIG consortium.

Nat Clin Pract Oncol. 2006 Oct;3(10):540-51. Review.

PMID:
17019432
8.

MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients.

Slodkowska EA, Ross JS.

Expert Rev Mol Diagn. 2009 Jul;9(5):417-22. doi: 10.1586/erm.09.32. Review.

PMID:
19580427
9.

Impact of gene expression profiling tests on breast cancer outcomes.

Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN.

Evid Rep Technol Assess (Full Rep). 2007 Dec;(160):1-105. Review.

10.

A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.

Jézéquel P, Campone M, Roché H, Gouraud W, Charbonnel C, Ricolleau G, Magrangeas F, Minvielle S, Genève J, Martin AL, Bataille R, Campion L.

Breast Cancer Res Treat. 2009 Aug;116(3):509-20. doi: 10.1007/s10549-008-0250-8. Epub 2008 Nov 20.

PMID:
19020972
11.

Breast cancer expression profiling: the impact of microarray testing on clinical decision making.

Modlich O, Prisack HB, Bojar H.

Expert Opin Pharmacother. 2006 Oct;7(15):2069-78. Review.

PMID:
17020433
12.

Adjuvant chemotherapy--yes or no? Prognostic markers in early breast cancer.

Piccart-Gebhart MJ, Sotiriou C.

Ann Oncol. 2007 Dec;18 Suppl 12:xii2-7. doi: 10.1093/annonc/mdm532. Review.

13.

Trial and error: prognostic gene signature study design altered.

Tuma RS.

J Natl Cancer Inst. 2005 Mar 2;97(5):331-3. No abstract available.

14.

[Has the time arrived for gene expression use at the bedside?].

D'Hondt V, Piccart M, Sotiriou C.

Bull Cancer. 2008 Mar;95(3):336-43. doi: 10.1684/bdc.2008.0593. Review. French.

PMID:
18390414
15.

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.

Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher WM.

Expert Opin Biol Ther. 2005 Aug;5(8):1069-83. Review.

PMID:
16050784
16.

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.

Ross JS.

Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf. Review.

PMID:
19546609
17.

Integrated gene expression profile predicts prognosis of breast cancer patients.

Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, Jin WR, Shao ZM.

Breast Cancer Res Treat. 2009 Jan;113(2):231-7. doi: 10.1007/s10549-008-9925-4. Epub 2008 Feb 16.

PMID:
18278552
18.

Multiple gene signatures aim to qualify risk in breast cancer.

Tuma RS.

J Natl Cancer Inst. 2005 Mar 2;97(5):332. No abstract available.

19.

Development of the 21-gene assay and its application in clinical practice and clinical trials.

Sparano JA, Paik S.

J Clin Oncol. 2008 Feb 10;26(5):721-8. doi: 10.1200/JCO.2007.15.1068. Review.

PMID:
18258979
20.

Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

Correa Geyer F, Reis-Filho JS.

Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Review.

PMID:
19103611
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk